Cargando…
A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
BACKGROUND: Variation in an individual’s genetic status can impact the development of pancreatic ductal adenocarcinoma; however, the m ajority of familial pancreatic cancers (FPC) cannot yet be attributed to a specific inherited mutation. We present data suggesting a correlation between loss-of-func...
Autores principales: | Nevler, Avinoam, Muller, Alexander J, Cozzitorto, Joseph A, Goetz, Austin, Winter, Jordan M, Yeo, Theresa P, Lavu, Harish, Yeo, Charles J, Prendergast, George C, Brody, Jonathan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047862/ https://www.ncbi.nlm.nih.gov/pubmed/29426021 http://dx.doi.org/10.1016/j.jamcollsurg.2017.12.052 |
Ejemplares similares
-
Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021) -
Precious Data: Interim Report from the Jefferson Pancreas Tumor Registry
por: Yeo, Theresa P., et al.
Publicado: (2018) -
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020) -
Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2
por: Jusof, Felicita F, et al.
Publicado: (2017) -
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
por: Moon, Yong Wha, et al.
Publicado: (2015)